Results 211 to 220 of about 39,697 (260)

Electroconvulsive therapy in an older patient with recurrent major depressive disorder and a permanent pacemaker: A case report. [PDF]

PCN Rep
Omori W, Kodaka N, Oga K, Masuda Y, Okada G.   +4 more
europepmc   +1 more source

Treatment patterns in patients with treatment-resistant depression in Danish patients with major depressive disorder

Journal of Affective Disorders, 2021
To describe treatment patterns in patients with treatment-resistant depression (TRD) and major depressive disorder (MDD) stratified by depression severity and year of diagnosis. Patterns of treatment were also compared to country-specific guidelines.All adults registered first time with a hospital contact due to MDD from 1996 through 2015 were ...
Frederikke Hørdam Gronemann, Janne Petersen, Kristoffer Jarlov Jensen   +2 more
exaly   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Brexpiprazole for treatment-resistant major depressive disorder

Expert Opinion on Pharmacotherapy, 2019
Introduction:Treatment-resistant depression (TRD), seldom interchangeably referred to as 'depression inadequately responding to the standard antidepressant drug,' carries a significant burden. The atypical antipsychotics represent a popular augmentation strategy for antidepressant-resistant depression, although their efficacy/safety profiles vary ...
Fornaro M., Fusco A., Anastasia A., Cattaneo C. I., De Berardis D.   +4 more
openaire   +3 more sources

Axis III disorders in treatment-resistant major depressive disorder

Psychiatry Research, 2003
A number of naturalistic studies have found that medical co-morbidity conveys a worse long-term prognosis in the treatment of major depressive disorder (MDD). The purpose of this study was to test whether the presence of co-morbid medical conditions can predict clinical response in patients with treatment-resistant MDD (TRD) treated with open-label ...
George I, Papakostas, Timothy, Petersen, Dan V, Iosifescu, Pamela A, Roffi, Jonathan E, Alpert, Jerrold F, Rosenbaum, Maurizio, Fava, Andrew A, Nierenberg   +7 more
openaire   +2 more sources

The ‘Dalhousie Serotonin cocktail’ for treatment-resistant major depressive disorder

Journal of Psychopharmacology, 2001
We describe the successful treatment of five patients with treatment-resistant major depressive disorder (TR-MDD) with a combination pharmacotherapy of pindolol, tryptophan and nefazodone. Five TR-MDD outpatients who had previously not responded to at least four different antidepressant medication trials were initiated on 300 mg/day of nefazodone, 7.5 ...
S Devarajan, Stan Kutcher
exaly   +3 more sources

The bipolar diathesis of treatment-resistant major depressive disorder

International Journal of Psychiatry in Clinical Practice, 2008
Objective. In this study, we determined the prevalence of bipolarity in patients with treatment-resistant depression (TRD) by investigating demographic and clinical characteristics, diagnostic subtypes and illness outcome of patients with resistant depression. Methods.
Young Sup, Woo, Jeong-Ho, Chae, Tae-Youn, Jun, Kwang-Soo, Kim, Won-Myong, Bahk   +4 more
openaire   +2 more sources

Intravenous Ketamine for Treatment-Resistant Major Depressive Disorder

Annals of Pharmacotherapy, 2012
OBJECTIVE: To evaluate the literature regarding the efficacy and safety of intravenous ketamine for treatment-resistant major depressive disorder (MDD). DATA SOURCES: A MEDLINE search (1966-September 2011) was performed using the terms
Jordan R, Covvey, Alexis Noble, Crawford, Denise K, Lowe   +2 more
openaire   +2 more sources